Literature DB >> 23422091

All vessels are not created equal.

Diane R Bielenberg1, Patricia A D'Amore.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23422091      PMCID： PMC5691336          DOI： 10.1016/j.ajpath.2013.01.008

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  33 in total

1.  Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.

Authors:  Marsha A Moses; Jay Harper; Judah Folkman
Journal:  N Engl J Med       Date:  2006-06-15       Impact factor: 91.245

Review 2.  Biological basis of therapeutic lymphangiogenesis.

Authors:  Camilla Norrmén; Tuomas Tammela; Tatiana V Petrova; Kari Alitalo
Journal:  Circulation       Date:  2011-03-29       Impact factor: 29.690

3.  Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.

Authors:  Kelly L Betterman; Sophie Paquet-Fifield; Marie-Liesse Asselin-Labat; Jane E Visvader; Lisa M Butler; Steven A Stacker; Marc G Achen; Natasha L Harvey
Journal:  Am J Pathol       Date:  2012-10-11       Impact factor: 4.307

4.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

Authors:  L E Benjamin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

5.  Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling.

Authors:  Peter Baluk; Wilfred W Raymond; Erin Ator; Lisa M Coussens; Donald M McDonald; George H Caughey
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-04-09       Impact factor: 5.464

6.  alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.

Authors:  Tatsuma Okazaki; Amy Ni; Oluwasheyi A Ayeni; Peter Baluk; Li-Chin Yao; Doerte Vossmeyer; Gunther Zischinsky; Grit Zahn; Jochen Knolle; Claudia Christner; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

Review 7.  Potential therapeutic strategies for lymphatic metastasis.

Authors:  Bernadette M M Zwaans; Diane R Bielenberg
Journal:  Microvasc Res       Date:  2007-09-19       Impact factor: 3.514

8.  Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.

Authors:  Tetsuichiro Inai; Michael Mancuso; Hiroya Hashizume; Fabienne Baffert; Amy Haskell; Peter Baluk; Dana D Hu-Lowe; David R Shalinsky; Gavin Thurston; George D Yancopoulos; Donald M McDonald
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 9.  Lymphangiogenesis: in vitro and in vivo models.

Authors:  Françoise Bruyère; Agnès Noël
Journal:  FASEB J       Date:  2009-09-02       Impact factor: 5.191

10.  Transgenic overexpression of interleukin-1β induces persistent lymphangiogenesis but not angiogenesis in mouse airways.

Authors:  Peter Baluk; Anna Hogmalm; Maija Bry; Kari Alitalo; Kristina Bry; Donald M McDonald
Journal:  Am J Pathol       Date:  2013-02-04       Impact factor: 4.307
View more
  1 in total

Review 1.  Inflammation-associated lymphangiogenesis: a double-edged sword?

Authors:  Honsoul Kim; Raghu P Kataru; Gou Young Koh
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.